| 19.4.2021 | Analysis of proteins in plasma in relation to breast cancer with MRM mass spectrometry | Selma Dögg Magnúsdóttir 1994- |
| 31.1.2019 | Athugun á þéttni/styrk beta-laktam lyfja sem gefin eru með langtíma innrennsli hjá sjúklingum sem fá meðferð utan sjúkrahúss | Andri Örn Erlingsson 1984- |
| 27.4.2020 | Biomarker analysis for APRT deficiency diagnosis using UPLC-MS/MS | Pálmi Þorgeirsson 1992- |
| 3.5.2011 | Development of a LC-MS/MS Method for the Quantification of Cortisol and Cortisone | Arndís Sue Ching Löve 1985- |
| 17.5.2013 | Development of a sample preparation method for the detection and identification of cholesterol in a Parkinson’s disease model utilizing MALDI-MSI | Ingólfur Birgisson 1988- |
| 28.4.2017 | Development of highly sensitive LC-ESI MS/MS method for neurotransmitters and MALDI imaging analysis on β-N-methylamino-L-alanine (BMAA) neurotoxin | Ásdís Alexandra Lee 1992- |
| 29.4.2019 | Development of UPLC-MS/MS method for quantification of cefazolin and flucloxacillin for quality analysis of OPAT elastomeric pumps | Snæfríður Dröfn Pétursdóttir 1992- |
| 25.4.2018 | Development of UPLC-MS/MS method for therapeutic drug monitoring for patients with APRT deficiency | Þorsteinn Hjörtur Bjarnason 1990- |
| 20.10.2009 | Effects of polymorphic NAT2 on thalidomide treatment in prostate cancer | Silja Þórðardóttir 1982- |
| 2.5.2013 | Effects of Protolichesterinic Acid on Lipid Composition in Cultured Cancer Cells | Signý Jóhannesdóttir 1987- |
| 30.4.2014 | Evaluation of Lipid Composition in Several Cancer Cell Lines by Mass Spectrometry | Andri Hallgrímsson 1986- |
| 20.10.2009 | Influence of CYP11A1 (TTTTA)n polymorphism on disease progression, serum androgens, prognosis and risk in men with prostate cancer | Jóhann Gunnar Jónsson 1982- |
| 19.4.2024 | Isolation of plasma-derived extracellular vesicles using immunoaffinity capture for breast cancer biomarker discovery | Bjarni Björnsson 2000- |
| 29.4.2019 | Labeling of human cells using 13C labeled nutrients and metabolite tracking in co-culture | Gunnar Jökull Johns 1994- |
| 25.4.2018 | Lipidomic profiling of cancer cell lines using multivariate data analysis | Rebekka Rós Baldvinsdóttir 1990- |
| 25.4.2018 | A MALDI-MSI method to detect neuropeptides in the basal ganglia of the brain | Halla Gunnarsdóttir 1991- |
| 30.4.2019 | Mass Spectrometry Based Diagnostics for APRT Deficiency: A Validation of a UPLC-MS/MS Urinary Assay for Absolute Quantification of 2,8-dihydroxyadenine and Adenine | Þórður Hermannsson 1991- |
| 19.4.2021 | Mass spectrometry-based enzymatic histochemistry methods for in situ imaging of catecholamine biotransformations on brain tissue sections | Sigrún Arna Jónasdóttir 1994- |
| 29.4.2019 | Metabolic profiling of cyanobacterial extracts using multivariate data analysis for their anti-obesity properties | Baldvin Gestsson 1992- |
| 30.4.2019 | Metabolites of in vitro colon cancer cells and their metabolic symbiosis with stromal cancer-associated fibroblasts | Kári Arnarson 1994- |
| 28.4.2016 | Optimization of Quantitative Clinical UPLC-MSMS Method for 2,8-Dihydroxyadenine and Oxypurinol with Design of Experiement | Ómar Rafn Stefánsson 1985- |
| 28.4.2016 | Pre-validation of UPLC-QqQ-MS/MS Procedure for Quantification of 2,8-Dihydroxyadenine in Human Urine | Guðrún Linda Sveinsdóttir 1991- |
| 27.4.2020 | Profiling metabolites in breast cancer tissue using DESI-MSI | Hákon Ellertsson 1994- |
| 30.4.2012 | Quantification of the Lipids 5-HETE, 12-HETE and LTB4 in Cultured Cancer Cells after Treatment with Protolichesterinic Acid | Sigríður Þóra Kristinsdóttir 1986- |
| 2.5.2017 | Sample Preparation Strategies for Breast Cancer Studies: Focus on Alpha-1-Acid Glycoprotein by means of MALDI-TOF mass spectrometry | Auðunn Rúnar Gissurarson 1991- |
Íslenska
